A new study, conducted by the NYU Grossman School of Medicine in New York City, found no link between drugs for lowering blood pressure and is not associated with the higher risk of COVID-19.
A team of researchers focused on angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, beta-blockers, calcium channel blockers, and thiazide diuretics in their study. For the study, they analyzed data from 12,594 people who were tested for COVID-19, and 5,894 of them had positive results. Among individuals who were tested positive, 4,357 also had hypertension.
Nevertheless, the assessment of potential links between medication history and the likelihood of testing positive for COVID-19 didn’t show an association between any single [antihypertensive] medication class and an increased likelihood of a positive test.
Lead investigator Dr. Harmony Reynolds comments on the results of the research: “Our findings should reassure the medical community and patients about the continued use of these commonly prescribed medications, which prevent potentially severe heart events in their own right.”
A new study from Shanghai Jiao Tong University, in China, suggests that larger thigh circumference can be connected to lower blood pressure in overweight people or people with obesity.
For the study, a team of researchers analyzed data received from a larger study, which included information on 9,520 people aged over 40 with 3,095 men and 6,425 women.
For study purposes, the participants filled in a questionnaire that included questions regarding hypertension. The doctors also measured the thigh circumferences of the participants and registered the average circumference of each participant’s thighs.
Study author Zhen Yang, Ph.D., says: “The most likely cause of this association is that there is more thigh muscle and/or fat deposited under the skin which secretes various beneficial substances that help keep blood pressure in a relatively stable range.”
In a new study, researchers from Spain determined the best time for people with hypertension to take their blood pressure pills which is at bedtime, not in the morning.
To come to such a conclusion, the researchers analyzed data from the Hygia Chemotherapy Trial, which is the largest and longest-lasting clinical trial examining the effects of antihypertensive therapy timing on the risk of cardiovascular events.
The leader of the Hygia project Ramón C. Hermida, Ph.D., comments: “The results of this study show that patients who routinely take their antihypertensive medication at bedtime, as opposed to when they wake up, have better-controlled blood pressure and, most importantly, a significantly decreased risk of death or illness from heart and blood vessel problems.”
A new study, recently published in the European Journal of Preventive Cardiology, suggests that exposure to blue light may help reduce high blood pressure.
For the study, a team of researchers assessed whether blue light exposure could produce enough nitric oxide to significantly reduce high blood pressure. They involved 14 male participants aged between 30 and 60 years without a previous diagnosis of cardiovascular conditions.
The authors of the study come into a conclusion: “Our present study demonstrates for the first time that whole-body blue light exposure at doses that are comparable to daily sunlight exposure decreases systolic blood pressure […] in young, healthy male volunteers.”
A new Danish research finds that one of the most popular blood pressure drug used around the globe to treat hypertension can increase the risk of developing skin cancer by seven times.
A team of scientists, led by Anton Pottegard, associate professor of clinical pharmacology at the University of Southern Denmark in Odense, examined the association between the common drug hydrochlorothiazide (HCTZ) and the risk of non-melanoma skin cancer.
Having analyzed the data of over 80,000 patients, the researchers found that those who took HTCS had 7 times higher chances to develop skin cancer.
Anton Pottergard comments: “We knew that hydrochlorothiazide made the skin more vulnerable to damage from the sun’s UV rays, but what is new and also surprising is that long-term use of this blood pressure medicine leads to such significant increase in the risk of skin cancer.”
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.